Literature DB >> 3872580

Computed tomography of parosteal osteosarcoma.

T M Hudson, D S Springfield, M Benjamin, F Bertoni, D A Present.   

Abstract

Twelve patients with parosteal osteosarcomas were evaluated by computed tomography (CT). CT accurately defined the extent of the tumors for purposes of surgical planning, although tumor bone often could not be distinguished from thickened host bone. Nine tumors invaded the medullary cavity, a feature that implies a poorer prognosis when the tumor also contains high-grade areas. Six CT studies accurately detected the medullary invasion, but three did not. Lucent areas within dense tumors contained either benign tissue or high- or low-grade tumor; CT did not differentiate among these different tissues. CT also did not reveal small satellite nodules of tumor beyond the main tumor mass.

Entities:  

Mesh:

Year:  1985        PMID: 3872580     DOI: 10.2214/ajr.144.5.961

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Case report 420: Parosteal osteosarcoma.

Authors:  M P Marks; S C Marks; H D Segall; C P Schwinn; D M Forrester
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

Review 2.  Surface lesions of the bones of the hand.

Authors:  S L J James; A M Davies
Journal:  Eur Radiol       Date:  2005-04-16       Impact factor: 5.315

3.  Custom-made intercalary endoprosthetic reconstruction for a parosteal osteosarcoma of the femoral diaphysis: A case report.

Authors:  Shi-Chang Zhao; Chang-Qing Zhang; Chun-Lin Zhang
Journal:  Oncol Lett       Date:  2015-08-24       Impact factor: 2.967

4.  Case report 711: Parosteal osteosarcoma of left femur.

Authors:  G Hermann; I F Abdelwahab; M J Klein; S Kenan; M M Lewis
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

5.  Parosteal osteosarcoma of the talus.

Authors:  W Kersjes; P Grebe; M Runkel; S Störkel; H Schild
Journal:  Skeletal Radiol       Date:  1995-04       Impact factor: 2.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.